AtaiBeckley ATAI announced the completion of dosing the last patient in the phase IIb Elumina study evaluating VLS-01 for ...

Adrian Hill is the recipient of the European Inventor Award 2026, in the research category, for his work developing a malaria vaccine ...

Kathryn Hardison covers breaking financial news for The Wall Street Journal. She previously reported on economic development at the Austin Business Journal in Texas. After graduating from the Missouri ...

Novavax’s dispute resolution and upcoming earnings call; Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company ...

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 11.3% in the afternoon session after documents revealed ...

Novavax Inc. company and executive profile by Barron's. View the latest NVAX company infomation and executive bios.

Is NVAX a good stock to buy? We came across a bullish thesis on Novavax, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on NVAX. Novavax, Inc.’s share was ...

Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with ...

Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...